The University of Cambridge, in partnership with the Progress Educational Trust, has led work to create the first ever UK guidelines for the generation and use of stem cell-based embryo models in research.
Scientists have grown ‘mini-placentas’ in the lab and used them to shed light on how the placenta develops and interacts with the inner lining of the womb – findings that could help scientists better understand and, in future, potentially treat pre-eclampsia.
Up to 3,500 first time mums are due to take part in a study led by Cambridge researchers to understand why some will develop pre-eclampsia and placental complications during pregnancy and whether it effects their long-term health.
Researchers have mapped the complete trajectory of placental development, helping shed new light on why pregnancy disorders happen.
New model embryo, using mouse stem cells, reaches a further point in development than has been achieved in any other stem cell-derived model.
Researchers studying mice have found the first evidence of how a mother’s gut microbes can help in the development of the placenta, and the healthy growth of the baby.
Scientists have identified the biochemical signals that control the emergence of the body pattern in the primate embryo. This will guide work to understand birth defects and pregnancy loss in humans.
The nine Cambridge researchers were all selected for their exceptional contributions to science.
Scientists have identified key molecular events in the developing human embryo between days 7 and 14 - one of the most mysterious, yet critical, stages of our development.
Women who will develop potentially life-threatening disorders during pregnancy can be identified early when hormone levels in the placenta are tested, a new study has shown.
© 2024 University of Cambridge